跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 702 条关于
“Bria-TILsRx”
全部
702
临床试验
501
药物
103
机构
14
资讯
84
去年
BriaPro Develops Novel Antibodies Targeting B7-H3 for Multi-Cancer Immunotherapy Applications
去年
BriaPro Files Patent for TILsRx Platform Targeting Multiple Cancer Types with Novel Multivalent Immunotherapy
3天前
DSMB Clears BriaCell's Phase 3 Bria-ABC Study of Bria-IMT Plus Checkpoint Inhibitor for Seventh Straight Time
2年前
Bria-IMT Shows Promise in Metastatic Breast Cancer, Including Brain Metastasis
3年前
BriaCell Advances Pivotal Study for Bria-IMT in Metastatic Breast Cancer Following Positive FDA Feedback
去年
BriaCell's Bria-OTS Shows Promise in Metastatic Breast Cancer with Lung Metastasis Resolution
2年前
FDA Authorizes Expanded Access to Bria-IMT™ for Metastatic Breast Cancer Patients
去年
BriaCell's Phase 3 Trial of Bria-IMT™ for Metastatic Breast Cancer Progresses
去年
BriaCell Therapeutics to Raise US$5.5 Million in Public Share Offering to Advance Bria-IMT
去年
BriaCell's Bria-IMT™ Shows Promise in Metastatic Breast Cancer Phase 2 Trial
第 1 页,共 9 页
上一页
下一页